These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 16186470)

  • 1. Ability of physicians to diagnose and manage illness due to category A bioterrorism agents.
    Cosgrove SE; Perl TM; Song X; Sisson SD
    Arch Intern Med; 2005 Sep; 165(17):2002-6. PubMed ID: 16186470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition and management of bioterrorism infections.
    O'Brien KK; Higdon ML; Halverson JJ
    Am Fam Physician; 2003 May; 67(9):1927-34. PubMed ID: 12751654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histopathology and immunohistochemistry in the diagnosis of bioterrorism agents.
    Guarner J; Zaki SR
    J Histochem Cytochem; 2006 Jan; 54(1):3-11. PubMed ID: 16148309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical management of potential bioterrorism-related conditions.
    Adalja AA; Toner E; Inglesby TV
    N Engl J Med; 2015 Mar; 372(10):954-62. PubMed ID: 25738671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Threats in bioterrorism. I: CDC category A agents.
    Darling RG; Catlett CL; Huebner KD; Jarrett DG
    Emerg Med Clin North Am; 2002 May; 20(2):273-309. PubMed ID: 12120480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' understanding of the regulation of dietary supplements.
    Ashar BH; Rice TN; Sisson SD
    Arch Intern Med; 2007 May; 167(9):966-9. PubMed ID: 17502539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioterrorism's invisible threats: heightened awareness will help nurses identify real and suspected bioterrorism.
    Altman GB
    Nurs Manage; 2002 Jan; 33(1):43, 45-7. PubMed ID: 11984331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioterriorism: from threat to reality.
    Atlas RM
    Annu Rev Microbiol; 2002; 56():167-85. PubMed ID: 12142472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioterrorism: class A agents and their potential presentations in immunocompromised patients.
    Richard JL; Grimes DE
    Clin J Oncol Nurs; 2008 Apr; 12(2):295-302. PubMed ID: 18390465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular diagnostic techniques for use in response to bioterrorism.
    Firmani MA; Broussard LA
    Expert Rev Mol Diagn; 2003 Sep; 3(5):605-16. PubMed ID: 14510181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of illness associated with the intentional release of a biologic agent.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2001 Oct; 50(41):893-7. PubMed ID: 11686473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of patients exposed to biologic weapons.
    Yetman RJ; Parks D; Taft E
    J Pediatr Health Care; 2002; 16(5):256-61. PubMed ID: 12226595
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of an online bioterrorism continuing medical education course.
    Casebeer L; Andolsek K; Abdolrasulnia M; Green J; Weissman N; Pryor E; Zheng S; Terndrup T
    J Contin Educ Health Prof; 2006; 26(2):137-44. PubMed ID: 16802314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infectious agents of bioterrorism: a review for emergency physicians.
    Kman NE; Nelson RN
    Emerg Med Clin North Am; 2008 May; 26(2):517-47, x-xi. PubMed ID: 18406986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biological and chemical terrorism: recognition and management.
    Noeller TP
    Cleve Clin J Med; 2001 Dec; 68(12):1001-2, 1004-9, 1013-6. PubMed ID: 11765118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioterrorism and primary care].
    Mayer Pujadas MA; Alvarez Pasquín MJ; Gómez Marco J; Redondo Sánchez J; Muñoz Gutiérrez J; Cereceda Ferrés M; Batalla Martínez C; Comín Bertrán E; Pareja Bezares A; Piñeiro Guerrero R; Niño Martín V; Arranz Izquierdo J; Carceller P; Nodar Martín E; Ortega Martínez J; Vázquez Villegas J; ;
    Aten Primaria; 2002 Oct; 30(6):392-400. PubMed ID: 12396947
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis and management of suspected cases of bioterrorism: a pediatric perspective.
    Patt HA; Feigin RD
    Pediatrics; 2002 Apr; 109(4):685-92. PubMed ID: 11927716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous manifestations of category A bioweapons.
    Aquino LL; Wu JJ
    J Am Acad Dermatol; 2011 Dec; 65(6):1213.e1-1213.e15. PubMed ID: 21777993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bioterrorism].
    Sata T
    Nihon Hoigaku Zasshi; 2005 Oct; 59(2):119-25. PubMed ID: 16296383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioterrorism.
    Bates N; Asgari-Jirhandeh N
    Emerg Nurse; 2001 Dec-2002 Jan; 9(8):21-5. PubMed ID: 11774753
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.